J&J Expands Global Access To Tuberculosis Pill Bedaquiline Following Increased Pressure From Novelist, Other Activists

STAT (7/14, Tsanni, Mast, Silverman, Subscription Publication) reported, “Advocates have been fighting Johnson & Johnson for years over a patent on a lifesaving tuberculosis pill” called bedaquiline. On Thursday, advocates “won a partial victory as the Un...